Skip to main content
. 2020 Mar 29;22(7):1141–1150. doi: 10.1111/dom.14015

Figure 5.

Figure 5

Adverse event incidence rate ratios, empagliflozin versus placebo, by TRS‐HFDM category. Incidence rates are given per 100 patient years. †Based on 79 MedDRA preferred terms. ‡Based on 88 MedDRA preferred terms. §Plasma glucose ≤70 mg/dL and/or requiring assistance. ¶Based on 8 MedDRA preferred terms. ††Based on the narrow standardized MedDRA query “acute renal failure”. CI, confidence interval; TRS‐HFDM, Thrombolysis in Myocardial Infarction Risk Score for Heart Failure in Diabetes